Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy

Author(s):
Reinders, M.E.J. (0000-0001-9543-567X); Roemeling-van Rhijn, M.; Khairoun, M.; Lievers, E.; Vries, D.K. de; Schaapherder, A.F.M.; Wong, S.W.S.; Zwaginga, J.J.; Duijs, J.M.; Zonneveld, A.J. van; Hoogduijn, M.J.; Fibbe, W.E. (0000-0001-8539-9011); Fijter, J.W. de; Kooten, C. van (0000-0002-6257-0899); Rabelink, T.J.; Roelofs, H.
Published
2013
Publication type
Article / Letter to editor
autologousmesenchymal stromal cellstransplant recipients
Date issued
2013-06-30
Language
English
Is part of
Cytotherapy (2013), Vol. 15, no. 6, p. 663-672
hdl
1887/106335
doi
10.1016/j.jcyt.2013.01.010